

HY-121659 · 50 mg
MedChemExpress · Cat: HY-121659
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/dcfbc.html
Description
DCFBC is a prostate-specific membrane antigen PSMA inhibitor that can be used for small animal positron emission tomography PET imaging. DCFBC labeled with F18 18F DCFBC can images in severe combined immunodeficient mice. 18F DCFBC uptake is higher in PIP tumors, but almost absent in FLU tumors. 18F DCFBC uptake is also high in the kidney and bladder, but the radioactivity washout time is shorter than that in PIP tumors. Indicating that 18F DCFBC can specifically localize to PSMA+ expressing tumors and is applicable to the study of prostate cancer.







